Data / Drug companies / Acetaminophen, guaifenesin
Acetaminophen, guaifenesin: 6 companies and 10 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Acetaminophen, guaifenesin is listed in the FDA National Drug Code Directory by 6 companies, with 10 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, liquid filled; tablet, film coated; capsule, gelatin coated, and the newest product started marketing on August 3, 2026.
The request: Get every company that lists acetaminophen, guaifenesin in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 6
- Products
- 10
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Maximum Strength Mucinex Sinus-Max Pressure, Pain and Cough, Pain, Headache and Congestion, Maximum Strength Mucus Relief Plus Pain and Headache, Vicks Sinex Severe Pain, Mucus and Chest Congestion, Coricidin HBP Maximum Strength Cold Flu And Chest Congestion, Tylenol Cold Plus Flu Plus Chest Congestion, Daytime, Mucinex Cold and Flu
- openFDA record search
- api.fda.gov
Companies that list acetaminophen, guaifenesin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Reckitt Benckiser LLC | 4 | capsule, liquid filled; tablet, film coated | Over the counter monograph drugs | June 1, 2025 |
| CVS Woonsocket Prescription Center, Incorporated | 2 | tablet, film coated; capsule, liquid filled | Over the counter monograph drugs | April 29, 2026 |
| Bayer HealthCare LLC. | 1 | capsule, gelatin coated | Over the counter monograph drugs | May 1, 2022 |
| Kenvue Brands LLC | 1 | tablet, film coated | Over the counter monograph drugs | March 6, 2026 |
| Shield Pharmaceuticals Corp | 1 | capsule, liquid filled | Over the counter monograph drugs | May 6, 2026 |
| The Procter & Gamble Manufacturing Company | 1 | capsule, liquid filled | Over the counter monograph drugs | August 3, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 5 | 50% |
| Tablet, film coated | 3 | 30% |
| Capsule, gelatin coated | 1 | 10% |
| Tablet | 1 | 10% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 10 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Expectorant | 10 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.